Breast cancer, leukemia, malignant lymphoma (Hodgkin'
Conditions
Interventions
Sponsors
Saitama Medical Center, Saitama Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patients must: 1 meet the disease and age criteria 2 have consented the study in a written form 3 be under the age 45 and obtain another written consent by the physician treating her primary disease at the time of autotransplantation 4 make an annual visit to the clinic during the period requiring cryopreservation
Exclusion criteria
Exclusion criteria: A patient is excluded from cryopreservation if: 1 she has a serious complication 2 she is unable to judge appropriately or unable to declare her wishes 3 this study will seriously delay the treatment for her primary disease 4 the physician treating her primary disease has decided that this study is not suitable for her A patient is excluded from autotransplantation if: 1 she has a serious complication 2 she is unable to judge appropriately or unable to declare her wishes 3 autotransplantation is a serious risk for her
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pregnancy rate by autotransplantation of cryopreserved ovarian tissue | — |
Countries
Japan
Contacts
Public ContactYasushi Takai
Saitama Medical Center, Saitama Medical University Department of Obstetrics and Gynecology
Outcome results
None listed